Ligand validation:4ILA

PLC: DIUNDECYL PHOSPHATIDYL CHOLINE

PLC is a Ligand Of Interest in 4ILA designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4ILA_PLC_D_403	7%	25%	0.337	0.821	1.39	1.66	6	5	1	0	81%	0.8095
4ILA_PLC_A_403	4%	27%	0.384	0.788	1.35	1.61	6	5	1	0	81%	0.8095
4ILA_PLC_E_403	3%	29%	0.439	0.797	1.31	1.54	5	5	2	0	81%	0.8095
4ILA_PLC_B_404	2%	76%	0.502	0.903	0.64	0.31	-	-	1	0	29%	0.2857
4ILA_PLC_C_403	1%	29%	0.453	0.672	1.28	1.55	4	5	1	0	81%	0.8095
4ILA_PLC_D_404	1%	71%	0.514	0.817	0.5	0.6	-	-	1	0	29%	0.2857
4ILA_PLC_B_403	1%	26%	0.464	0.649	1.41	1.6	7	5	1	0	81%	0.8095
4ILA_PLC_C_404	1%	70%	0.611	0.828	0.7	0.48	-	-	1	0	29%	0.2857
4ILA_PLC_A_404	0%	74%	0.659	0.74	0.56	0.44	-	-	0	0	29%	0.2857
4ILA_PLC_E_404	0%	77%	0.754	0.828	0.59	0.34	-	-	1	0	29%	0.2857
3UUB_PLC_F_320	16%	88%	0.19	0.908	0.45	0.22	-	-	0	0	17%	16.669999999999998
6HZ1_PLC_E_401	12%	95%	0.233	0.842	0.19	0.2	-	-	0	0	57%	0.5714
4QH5_PLC_E_403	10%	47%	0.272	0.806	1.1	0.94	2	2	0	0	81%	0.8095
6HZW_PLC_D_403	9%	11%	0.221	0.742	1.83	2.37	3	9	0	0	81%	0.8095
6HYW_PLC_D_401	8%	68%	0.272	0.783	0.48	0.74	-	1	0	0	81%	0.8095
4DOS_PLC_A_603	64%	52%	0.134	0.933	0.97	0.88	2	-	1	0	100%	0.869
4P00_PLC_A_922	12%	42%	0.283	0.836	1.12	1.12	2	3	1	0	90%	0.9048
4P02_PLC_B_802	10%	82%	0.251	0.892	0.26	0.54	-	-	0	0	26%	0.2619
5EJZ_PLC_B_803	10%	72%	0.261	0.91	0.3	0.77	-	-	1	0	21%	0.2143

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.